Lactobacillus sakei to Treat Sinusitis - Quick Reference Sheet

Lactobacillus sakei to Treat Sinusitis

Created on 09/26/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Grok 4 – Audit

Lactobacillus sakei is a food bacterium sold as a refrigerated powder and administered intranasally for long-running sinus inflammation. Nasal use has almost no human evidence that symptoms change. The case is how it might work, plus a mouse result in which one strain limited injury; a later lab study found a human-nose strain did not reseal a leaky lining. Uncertainty sits on symptoms, not on a settled verdict. (Full Review)

Protocol

Commercial powder, once daily
¼ teaspoon (1 g)
Lanto Sinus (proBio65) in sterile water, each nostril; the rest administered orally during symptoms. About 1 billion colony-forming units per gram is a label claim, not a tested dose.
Irrigation under study
Twice daily, 14 days
proBio65 in 240 mL distilled or boiled water after sinus surgery. No results yet. No comparison with once-daily use exists.
Kimchi-juice swab
Live, unpasteurized juice
Administered intranasally. Strain and count are unknown and vary by jar.
Time to effect
Lower atopic dermatitis scores
Over 12 weeks
Oral score change over 12 weeks. Does not bear on sinusitis.
Lower knee pain and function scores
12 weeks
Oral score change at 12 weeks. Does not bear on sinusitis.
Better cheek elasticity
5 weeks
Larger change versus placebo was clear at 5 weeks; only a trend at 8 weeks. Does not bear on sinusitis.

Benefits

Contraindications
  • Severe immune suppression (absolute neutrophil count below 500 per microliter, active chemotherapy, or the months after a blood stem-cell transplant)
  • Prosthetic heart valve, prior infective endocarditis, or a recent valve operation
  • Preterm infants
  • Known allergy to the organism or to the powder's other ingredients (microcrystalline cellulose, dextrose in the commercial product)
Key Interactions
  • Systemic antibiotics (ampicillin, amoxicillin, penicillin)
  • Topical nasal antibacterials and antiseptics (mupirocin, povidone-iodine rinses; same-day)
  • Other probiotic supplements
  • Supplements sometimes used for sinus symptoms (lactoferrin, saline irrigation)
  • Over-the-counter decongestant sprays (oxymetazoline)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal upset with oral use; invasive infection in vulnerable hosts
  • Speculative: Nasal irritation with topical use

Monitoring

Marker Target Why
SNOT-22 No organism-specific target. Change from the person's own baseline; a drop of at least 9 points is a widely cited noticeable change. About 12 points has been proposed for medicine-treated sinusitis. Neither number was derived for this organism. Sinus symptom burden
Body temperature No functional target. The person's own baseline and any new fever. Conventional fever cutoff is 38.0 °C. Any new fever is a reason to stop, not a dosing goal. Early flag for invasive infection
Nasal comfort after application No numeric target. New burning, bleeding, or sneezing. Local irritation from a topical dose
Days that an antibiotic or a steroid spray was used No numeric target Practical flare count

Cadence: Baseline before a nasal or oral course, again at about 2 weeks and at 4 to 6 weeks, then only if symptoms return.

Qualitative Assessment

  • Nasal airflow through both nostrils at rest
  • Facial pressure and post-nasal drip
  • Sense of smell
  • Sleep continuity, as an indirect marker of obstruction